Previously, we reported that adenovirus E1a protein behaves as a tumor suppressor in human cells. It apparently functions by transcriptionally inducing an array of epithelial cell adhesion genes, while repressing other cell-type speci®c genes, thus producing an epithelial phenotype. Concomitantly, the cells become sensitive to anoikis (apoptosis of epithelial cells detached from extracellular matrix), potentially causing tumor suppression. E1a protein interacts with the nuclear acetylases p300, CBP and P/CAF, and also with the co-repressor protein CtBP. In this study, we have determined the role of these interactions in E1a's phenotypic eects on human tumor cells. The results indicate that E1a's interaction with CtBP activates at least three epithelial cell adhesion gene promoters. The E-cadherin repressor appeared to be the CtBP-interacting protein d EF1/ZEB, which bound the ras-repressible E-boxes of the E-cadherin promoter. The E1a ± CtBP interaction also contributed to anoikissensitization. E1a's interactions with the nuclear acetylases conferred epithelial morphologies but did not activate epithelial genes. These latter interactions did not sensitize tumor cells to anoikis but nevertheless conferred tumor suppression. These results implicate CtBP as an antagonist of the epithelial phenotype and anoikis. They also indicate a new but unde®ned role for nuclear acetylases in maintaining the transformed phenotype. Oncogene (2000) 19, 3823 ± 3828.
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Keywords: E1a; CtBP; epithelial phenotype; anoikis; E-cadherin Studies of the mechanism of transformation by adenovirus E1a have identi®ed key cellular regulators of the cell cycle, transcription and dierentiation. In particular, E1a interacts with (1) retinoblastoma (Rb)-family proteins, which regulate cell cycle-related transcription factors in response to cyclin-dependent protein kinases; (2) nuclear acetylases such as p300/ CBP and P/CAF, which are adaptor proteins for numerous transcription factors, and (3) C-terminal Binding Protein (CtBP; Schaeper et al., 1995) , which is a co-repressor for numerous DNA-binding transcriptional repressor proteins (reviewed in Mannervik et al., 1999) . While the cell cycle progression potential of E1a is attributed to its interactions with the Rb-family proteins and the nuclear acetylases (reviewed in Kouzarides, 1999; Grana et al., 1998) , the CtBPinteraction domain attenuates the focus size and tumor malignancy of cells cotransfected with E1a and ras, by antagonizing the transforming eect of E1a in cis (Subramanian et al., 1989) .
Several years ago, we reported that E1a unexpectedly acted as a tumor suppressor in certain human tumor cell lines (Frisch, 1991) . Related eects of E1a were reported elsewhere (reviewed in Mymryk, 1996) , but these diered from the eect that we reported in several signi®cant respects: (1) anti-metastatic eects of E1a had been reported in the context of E1a/ras transformed rodent cells (Pozzatti et al., 1986) , but, by contrast, E1a suppressed primary human tumor growth in our system (Frisch, 1991) ; (2) suppression of c-erbB2 expression was reported (Yu et al., 1991) , but E1a suppressed tumor growth of even non-c-erbB2-expressing tumor cells in our system (Frisch and Dolter, 1995) ; (3) induction of susceptibility to immunologic surveillance was reported (Cook et al., 1989) ; however, E1a conferred anchorage-dependence in vitro (Frisch, 1991; Frisch and Dolter, 1995) , which is independent of the immune system and would suce for tumor suppression in vivo; (4) E1a causes apoptosis when overexpressed by transient transfection (Rao et al., 1992) , but, in our system, retroviral transduction was used to obtain lower levels of expression which failed to induce apoptosis; (5) the C-terminal domain of E1a acted in cis to reduce transformation of rodent cells by E1a and ras (Subramanian et al., 1989) , but this domain's eect in the context of oncogenes other than E1a was not tested.
These considerations prompted a re-examination of the tumor suppression eect of E1a in human tumor cells. We subsequently observed that E1a induced human tumor cells of various lineages to adopt an epithelial phenotype (Frisch, 1994) , by the criteria of inducing epithelial cell adhesion molecules/junctional complexes, accompanied by cell polarization, and repressing other cell-type speci®c genes. Such epithelial features are often compromised during the oncogenic conversion of normal cells into carcinomas (reviewed in Behrens, 1999) . We therefore suspected that, conversely, the epithelial conversion induced by E1a might be related to its tumor suppression eect. In particular, epithelial cells are sensitive to`anoikis', wherein apoptosis is triggered by the loss of appropriate integrin-mediated cell-matrix contacts, causing cell survival to be anchorage-dependent (reviewed in Frisch and Ruoslahti, 1997) . E1a sensitized human tumor cells to anoikis (Frisch and Francis, 1994) , which might relate to its tumor suppression eect.
In this report, we have examined the E1a-protein interactions involved in epithelial conversion, anoikis and tumor suppression. We found that the E1a ± CtBP interaction was required for the induction of epithelial gene expression. In the case of the E-cadherin promoter, this resulted from E1a's disruption of a complex involving CtBP and dEF1/ZEB, a zinc ®nger-homeodomain repressor protein (Sekido et al., 1994) that controls muscle and lymphoid dierentiation (Sekido et al., 1994; Higashi et al., 1997; . Anoikis-sensitivity resulted from the E1a ± CtBP interaction as well. Unexpectedly, the interactions of E1a with nuclear acetylases suppressed tumorigenicity in two cell systems, even though this interaction is thought to provoke cell cycle progression.
Wild-type E1a converts A2058 melanoma and HT1080 ®brosarcoma (subclone H4) cells into nontumorigenic cells (Frisch, 1991) expressing epithelial cell adhesion molecules (Frisch, 1994) . We expressed E1a mutants that selectively lack the ability to interact with speci®c cellular E1a-target proteins (Table 1) in these cells by using a high-eciency retroviral transduction system (Kinsella and Nolan, 1996) ; stable expression of the mutant E1a proteins was veri®ed non-quantitatively by Western blotting (data not shown).
Observation of the cell morphologies revealed that individual mutation of either the nuclear acetylase-or CtBP-interaction domains did not aect E1a's ability to convert melanoma cells into a¯at, epithelioid morphology ( Figure 1 ); E1a mutated in both domains failed to do so (but enlarged the cells slightly). The ®rst 80 amino acids of E1a alone (D81-243), which binds only nuclear acetylases but not Rb or CtBP, was able to convert the cells morphologically. In summary, E1a-nuclear acetylase and E1a ± CtBP interactions each suced to produce an epithelioid morphology.
We then assayed the stable cell lines for the induction of two of the epithelial genes examined in our previous study, desmoglein-2 and plakoglobin (Frisch, 1994) . Analysis of Northern blots ( Figure 1 ) revealed that these two genes are regulated coordinately. Among the mutants derived from full-length E1a, a single mutant, 233PL?AS, which interacts with all known E1a target proteins except CtBP (Boyd et al., 1993) , was unique in that it consistently failed to induce desmoglein-2/plakoglobin. Because these results could be aected somewhat by clonal variations (and are therefore not presented quantitatively), several independently derived cell lines that expressed wildtype or 233PL?AS mutant forms of E1a were examined, which quantitatively con®rmed the CtBP eect ( Figure 1 ). To further rule out possible artifacts due to clonal variation, melanoma cells were infected with E1a wild-type or E1a 233PL?AS retroviruses and the mixed populations were analysed 4 days later for epithelial gene induction, producing similar results to those of the stable cell lines (Figure 1 ). The combined results indicate that the interaction of E1a with CtBP ± which is known to displace the latter from repression complexes (Turner and Crossley, 1998) ± induces epithelial cell adhesion molecule genes such as desmoglein-2 and plakoglobin.
A third epithelial cell adhesion molecule gene promoter, E-cadherin, was analysed by transient transfection of the E-cadherin promoter because the endogenous gene promoter was refractory to induction, perhaps due to irreversible inactivation by methylation (Yoshiura et al., 1995) or rearrangement (Ji et al., 1997) . For these experiments, a minimal E-cadherin promoter (780 to +10) sequence containing binding sites for Sp1, NF1/CTF and repressors (see below) was fused to a luciferase reporter. E1a induced this promoter strongly in HT1080 ®brosarcoma cells (Figure 2a ), even though this form of E1a (243 aa) represses most gene promoters in co-transfection experiments (Rochette-Egly et al., 1990) . The Ecadherin promoter contains two E-box elements which are thought to be involved in silencing it in E-cadherin non-expressing cells (Giroldi et al., 1997) . Consistent with this, the promoter was repressed in HT1080 ®brosarcoma cells through its two E-boxes, as mutation of both of these elements increased the activity about 10-fold (data not shown) and rendered the promoter resistant to induction by E1a (Figure 2a ). E1a amino acids 141 ± 243 (encoded by exon 2) induced the promoter even more strongly than did wild-type E1a. Mutation (233PL?AS) of the CtBP interaction domain abolished this induction, implicating the E1a ± CtBP interaction in the induction of this promoter as well.
When combined, these results suggested that the Ecadherin repressor protein must be capable of binding both to E-box sequences and to CtBP. The zinc ®nger-homeodomain repressor dEF1/ZEB binds E-boxes Rb-family Corbeil and Branton, 1994 D1 ± 140 p300, CBP, P/CAF, Rb Wang et al., 1993; Reid et al., 1998; Corbeil and Branton, 1994 D81 ± 243* Rb-family, CtBP Wang et al., 1993; Reid et al., 1998; Corbeil and Branton, 1994 D202 ± 243 CtBP Boyd et al., 1993 233PL?AS CtBP Boyd et al., 1993 ; this study *A C-terminal nuclear localization signal and HA-tag were appended to this coding sequence E1a mutants used in this study were previously characterized as indicated in the references, except the 233PL?AS mutant, which was shown to prevent the interaction of E1a with CtBP as follows. Gst-CtBP protein (2 mg; lanes 2 ± 4) or gst protein (lane 1) immobilized on glutathionesepharose was reacted in buer containing 200 mM NaCl and 0.25% Triton X-100 with in vitro translated E1a wild-type (lanes 1 and 2), E1a P233A (lane 3) or E1a 233PL?AS (lane 4), washed and analysed by PAGE (Sekido et al., 1994; Remacle et al., 1999) and represses transcription by recruiting CtBP (Postigo and Dean, 1999) . We therefore tested its potential as an Ecadherin repressor. Gel mobility shift analysis using HT1080 nuclear extracts (which contain dEF1/ZEB protein; Postigo et al., 1997) revealed a complex found speci®cally with E-cadherin promoter probes containing wild-type but not mutant E-boxes. This speci®c complex was abolished by incubation with anti-dEF1/ ZEB antibody (Figure 2b ), indicating that the major Ebox binding protein is identical to or closely related to dEF1/ZEB protein.
To test whether this binding repressed the Ecadherin promoter, a full-length ZEB expression construct (Postigo and Dean, 1999) was cotransfected with the promoter containing either wild-type or mutant E-boxes into MDCK epithelial cells, which express E-cadherin. ZEB repressed the wild-type promoter about threefold (Figure 2c) while not substantially aecting the mutant promoter. This repression was dependent on the CtBP interaction sites of ZEB as the double mutant of ZEB lacking these sites (Postigo and Dean, 1999) failed to repress. The data suggest that dEF1/ZEB is a potential E-cadherin repressor protein, which is consistent with the idea that E1a de-represses the E-cadherin promoter by binding CtBP.
Previously, we reported that E1a confers anoikissensitivity upon HT1080 and ras-transformed MDCK cells (Frisch and Francis, 1994) . To test whether epithelial conversion and anoikis-sensitization occurred by similar E1a-cellular protein interactions, a number of experiments were performed. Amino acids 1 ± 80 of E1a ± which converted the cells to an epithelial morphology without inducing epithelial gene expression ± did not sensitize the cells (Figure 3a) . Figure 1 The interaction of E1a with CtBP is required for maximal induction of the epithelial genes desmoglein-2 and plakoglobin. (a) E1a-nuclear acetylase and E1a ± CtBP interactions each suce to produce an epithelioid morphology in melanoma cells. Cell lines were constructed by infection with LZRS retroviruses packaged in FNX cells as described previously (Frisch, 1994) . E1a mutants were constructed by PCR and subcloned into the HIII-NotI site of the vector; all mutants were veri®ed by DNA sequencing. Following infection, three to ®ve clonal cell lines were established for each mutant, which were checked qualitatively for E1a expression on Western blots using either anti-E1a-C-terminus Ab-1 (Oncogene Research) or anti-HA epitope tag in the case of the D81-243 mutant, which included a sequence encoding this epitope as well as a C-terminal nuclear localization signal (using the sequence from pShooter, Invitrogen). Cell lines generated using the indicated E1a mutant-retroviruses were photographed by phasecontrast microscopy (*806 ®nal magni®cation). (a) E1a induced desmoglein-2 (DSG-2) and plakoglobin (PG) by interacting with CtBP. Representative stable cell lines expressing the indicated E1a mutants were assayed for induction of the DSG-2, PG and GAPDH by Northern blotting of equal amounts (15 mg) of total RNA. Northern blots were performed using total RNAs prepared with the Qiagen Rneasy kit and other reagents supplied by the Ambion Northern-Max kit, following manufacturer's instructions. (b) Quantitation of the eect of mutating the CtBP interaction domain (233PL?AS) on desmoglein-2 and plakoglobin induction in several independent stable cell lines. Western blots were used to quantitate the levels of DSG-2, PG, actin or E1a using antibodies from BioDesign, Transduction Labs, ICN and Calbiochem, respectively, and cell lysates containing equal amounts of protein.
Densitometric quantitation of the results, derived from NIH Image analysis, are presented to the right of the Western blots. (c) Transient induction of epithelial genes by E1a. A2058 cells were infected with E1a wild-type, E1a PL?AS, or empty LZRS retroviruses. Four days later, cell lysates were analysed for the indicated genes by Western blotting Interestingly, sensitization of A2058 melanoma cells required the E1a ± CtBP interaction (Figure 3a) , following both stable and transient expression of E1a. Sensitization of HT1080 cells was somewhat less dependent on CtBP interaction however, indicating that other E1a interactions may participate in certain cell types. Surprisingly, the E1a ± CtBP interaction ± in the context of full-length E1a ± was not required for tumor suppression (Figure 3b ). Moreover, the nuclear acetylase-binding domain of E1a (amino acids 1 ± 80) suced to suppress tumor growth nearly as well as full-length E1a. Because the CtBP interaction domain conferred anoikis-sensitivity, it would be expected to possess a second tumor suppression activity. However, this could not be determined directly, because E1a mutants containing extensive deletions of the nuclear acetylase interaction domain retarded cell growth substantially (by contrast with the other mutants, data not shown); thus, this issue remains to be resolved.
These results suggest a new role for CtBP as an antagonist of the epithelial phenotype. This provides a mechanism for E1a's induction of epithelial cell adhesion molecule genes in human tumor cells (Frisch, 1994) and explains why normal epithelial cells expressing wild-type E1a retain more epithelial characteristics than those expressing C-terminally deleted E1a (Gopalakrishnan and Quinlan, 1995) . Interestingly, CtBP is also a co-repressor for other repressor protein/silencer element systems that do not apparently relate to epithelial genes, such as Basic Kruppel-like Factor (Turner and Crossley, 1998) . This raises the question of why E1a does not also induce various non-epithelial genes. De-repression may suce to activate epithelial promoters speci®cally because their transactivator proteins (Sp1, NF1, etc.) are ubiquitous and nonp300-requiring. By contrast, promoters speci®c to other lineages (e.g., muscle, nerve, etc.) need tissue-speci®c transactivators that are not expressed in the cells under consideration and/or that need nuclear acetylase cofactors, which E1a inhibits. Thus, E1a converts the cells to the epithelial`default' phenotype (Frisch, 1997) by neutralizing both the repressive eect of CtBP and the activational eect of nuclear acetylases. The human E-cadherin promoter (nuc. 780 to +10, Giroldi et al., 1997) was fused to a luciferase coding sequence and cotransfected into HT1080 cells with the indicated mutants expressed in pcDNA3.1. The y-axis is fold stimulation of luciferase activity relative to co-transfected empty vector. Transient transfections were performed by using standard calcium phosphate transfection in HT1080 cells. The E-cadherin reporter was constructed by subcloning a double-stranded oligonucleotide containing the sequence 780 to +10 of the human E-cadherin gene into pGL3basic (Promega). Following transfection, extracts were prepared and assayed for luciferase activity using Promega reagents and a Berthold luminometer. A Western blot of the transiently transfected cells probed with E1a antibody (Calbiochem) is shown in the insert next to the histogram. (b) dEF1/ZEB interacts with the E-cadherin E-boxes. Nuclear extracts from HT1080 ®brosarcoma cells were prepared as described previously (Frisch and Morisaki, 1990) and were analysed for gel electrophoretic mobility shift using E-cadherin promoter oligonucleotides containing wild-type (wt: TGGCCGGCAGGTGAACCCTCAGTTAATCAGCGGTATAAAAAATGGTGCTCTAAAATTCACCTGGCTG-CAG) or mutant (mut: TGGCCGGAAGATGAACCCTCAGTTAATCAGCGGTATAAAAAATGGTGCTCTAAAAT-TAACTTGGCTGCAG) E-boxes under conditions described (Sekido et al., 1994) . Anti-dEF1/ZEB antibody was from Dr H Kondoh (Sekido et al., 1994) ; 1 ml of it or pre-immune serum (p.i.) containing 50% glycerol were pre-incubated with 2 ml of nuclear extract (*6 mg) for 15 min at 48 prior to electrophoresis. (c) dEF1/ZEB represses the E-cadherin promoter through the E-boxes, and requiring its CtBP-interaction sites. MDCK epithelial cells were cotransfected with E-cadherin promoter-luciferase constructs (0.8 mg) containing wild-type (wt) or mutant (mut) E-boxes together with full-length ZEB (0.8 mg) in pCIneo (Postigo and Dean, 1999) , or the truncated forms of ZEB bearing wild-type (ZEB-DB wt) or non-CtBP-interacting repression domains (ZEB-DB mut) using Eectene (Qiagen). Cells were grown to con¯uence prior to preparation and assay of luciferase constructs. Luciferase activity was calculated as fold increase over background obtained by transfection with empty luciferase vector (pGL3basic, Promega). (N.B., The results with the ZEB-DB constructs (Postigo and Dean, 1999) were further normalized against the cotransfected empty reporter vector, pGL3, which was aected slightly by these constructs)
The transcriptional down-regulation of E-cadherin is a widespread contributor to human carcinogenesis (Birchmeier et al., 1995; Guilford, 1999) and the mechanisms by which this promotes tumor progression are emerging (reviewed in Christofori and Semb, 1999) . Repression of the promoter through the two E-boxes is clearly important in this downregulation (Giroldi et al., 1997; Hajira et al., 1999) . Our present results suggest that dEF1/ZEB ± a repressor that is known to bind Eboxes and to repress by recruiting CtBP ± is one potential E-cadherin repressor protein. This protein can repress certain nonepithelial genes as well, and is present in most cell types. However, it is reasonable to expect the repressor to be fairly ubiquitous because many or all dierentiated cell types ± having arisen from embryonic`proto-epithelial' cells (Fleming and Johnson, 1988) ± must repress epithelial genes.
Other E-cadherin repressors probably exist; in fact, dEF1 knockout mice have severe skeletal defects in multiple cell lineages but still develop to term (Takagi et al., 1998) , showing that mesenchymal cell types can still arise in the absence of this factor. The eect of stably expressing human ZEB in epithelial cells is currently being assessed (Frisch, unpublished) as another approach. In this light, expression of the Drosophila ZEB homologue, zfh-1, is controlled by members of the snail family of transcription factors (Kosman et al., 1996) ; Snail has been proposed as an alternative E-cadherin repressor (Batlle et al., 2000; Cano et al., 2000) (although its repression activity appears to be non-speci®c in our preliminary experiments; data not shown). Another human member of this family, slug, causes epithelial to mesenchymal transitions when overexpressed (Savagner et al., 1997) . In any event, the E-box mediated repression of E-cadherin seen in spontaneous human tumors or in response to ras (Frisch, unpublished results) or HER2/cerbB2 (D'souza and Taylor-Papadimitriou, 1994) oncogenes may in some cases involve the regulation of dEF1/ ZEB-CtBP complexes. How this regulation occurs will be an interesting subject of future investigations. Parallel studies on how ras regulates the repression activity of a CtBP-interactive c-fos repressor called Net (CriquiFilipe et al., 1999) may prove informative in this regard. In this connection, a repressor that is highly homologous to dEF1/ZEB, SIP1, has recently been cloned (Verschueren et al., 1999 ).
E1a appears to achieve tumor suppression by anoikis-dependent and -independent mechanisms, involving the CtBP and nuclear acetylase interactions, respectively. The inhibition of nuclear acetylase activities by E1a is believed to trigger cell cycle progression (Yang et al., 1996) which is contradictory to the tumor suppression eect of E1a's N-terminus seen in two cell lines here. However, the eect of inhibiting nuclear acetylases on anchorage-dependence has not yet been tested and may resolve this discrepancy. The mechanism by which inhibition of CtBP by E1a sensitizes cells to anoikis has yet to be determined. Expression of epithelial cell adhesion molecules such as E-cadherin clearly promotes anoikis-sensitivity (Frisch and Francis, 1994) by mechanisms that are currently being investigated. Repressors such as dEF1/ZEB may possess additional apoptotic regulatory mechanisms which have not yet been described; in fact, certain other zinc ®nger transcription factors have been shown to regulate apoptosis (c.f., Inukai et al., 1999) . Figure 3 (a) Interaction of E1a with CtBP is required for maximal sensitization of tumor cells to anoikis. Cell lines indicated were placed in suspension for 6 h and then extracted under hypotonic lysis conditions. Equal amounts of protein were assayed for cleavage of the¯uorigenic caspase-3, 7 substrate, Ac-DEVD-AFC. Spontaneous apoptosis occurring prior to cell suspension (zerosuspension time DEVD cleavage) values were substracted. Caspase assays were performed as described previously (Frisch, 1999) . In the middle panel, the transiently infected A2058 cells described in Figure 1 were tested for anoikis similarly. (b) E1a-nuclear acetylase interactions suppress tumor growth in mice. A2058 or HT1080 (subclone H4) cells expressing the indicated E1a mutants were assayed for tumorigenicity in nude mice as described previously (Frisch and Dolter, 1995) using four mice, each injected at two sites, per cell line. The results represent the averages over three cell lines per E1a construct
